Please assess the completion status of the following clinical trial:

Trial Title: Effect of METOprolol in CARDioproteCtioN During an Acute Myocardial InfarCtion. The METOCARD-CNIC Trial.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Confirmed\* acute anterior wall myocardial infarction (ST segment elevation ≥ 2mm in ≥ 2 contiguous leads \[one of which should be V2, V3, or V4\]).~2. Killip class I or II on diagnosis.~   * Cases of non-confirmed infarction by enzymatic release (above 2 standard deviations from upper limit of CK and Troponin) are excluded from efficacy analysis but kept in the safety analysis.~Exclusion Criteria:~1. COPD or asthma on active bronchodilator therapy~2. Active treatment with beta blockers~3. Left bundle branch block or pacemaker.~4. Systolic blood pressure \<120 mmHg, Heart rate \<60 bpm, or AV block (PR˃240 mS or superior) on diagnosis.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Early metoprolol initiation strategy (Type: ACTIVE_COMPARATOR): None
- Delayed metoprolol initiation strategy (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).